TG Therapeutics, Inc.
US ˙ NasdaqCM ˙ US88322Q1085

Introduction

This page provides a comprehensive analysis of the known insider trading history of Sean A Power. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Sean A Power has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:TGTX / TG Therapeutics, Inc. CFO 708,111
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Sean A Power. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases TGTX / TG Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in TGTX / TG Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2012-09-14 TGTXD Power Sean A 3,400 2.2800 3,400 2.2800 7,752 730 9.5100 24,582 317.11
2012-09-13 TGTXD Power Sean A 1,000 2.2500 1,000 2.2500 2,250

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TGTX / TG Therapeutics, Inc. Insider Trades
Insider Sales TGTX / TG Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in TGTX / TG Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-01-06 TGTX Power Sean A 10,021 28.5340 10,021 28.5340 285,939 217 26.3900 -21,485 -7.51
2025-01-03 TGTX Power Sean A 11,337 30.2940 11,337 30.2940 343,443
2024-01-03 TGTX Power Sean A 47,867 16.9100 47,867 16.9100 809,431
2023-06-02 TGTX Power Sean A 73,647 26.7000 73,647 26.7000 1,966,375
2022-01-05 TGTX Power Sean A 9,653 18.3100 9,653 18.3100 176,746
2022-01-04 TGTX Power Sean A 75,312 19.2000 75,312 19.2000 1,445,990
2019-07-01 TGTX Power Sean A 17,654 8.4700 17,654 8.4700 149,529
2019-01-02 TGTX Power Sean A 37,275 4.1300 37,275 4.1300 153,946
2018-07-03 TGTX Power Sean A 35,000 13.1900 35,000 13.1900 461,650
2018-07-02 TGTX Power Sean A 12,191 13.2600 12,191 13.2600 161,653
2018-01-02 TGTX Power Sean A 32,006 8.5000 32,006 8.5000 272,051
2017-06-19 TGTX Power Sean A 30,000 11.0400 30,000 11.0400 331,200
2017-06-16 TGTX Power Sean A 29,976 11.1400 29,976 11.1400 333,933
2017-01-04 TGTX Power Sean A 8,816 4.5500 8,816 4.5500 40,113
2016-07-05 TGTX Power Sean A 50,426 5.9900 50,426 5.9900 302,052
2016-04-18 TGTX Power Sean A 10,000 10.1200 10,000 10.1200 101,200
2016-01-05 TGTX Power Sean A 22,790 11.2100 22,790 11.2100 255,476
2015-07-01 TGTX Power Sean A 50,054 16.4600 50,054 16.4600 823,889
2015-04-02 TGTX Power Sean A 11,000 15.5100 11,000 15.5100 170,610
2015-04-01 TGTX Power Sean A 12,800 15.5000 12,800 15.5000 198,400
2015-01-07 TGTX Power Sean A 12,344 16.4000 12,344 16.4000 202,442
2015-01-05 TGTX Power Sean A 54,057 16.3984 54,057 16.3984 886,448
2014-12-16 TGTX Power Sean A 38,041 16.4400 38,041 16.4400 625,394

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TGTX / TG Therapeutics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Sean A Power as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-01-30 2025-01-29 4 TGTX TG THERAPEUTICS, INC.
Common Stock
A - Award 87,500 708,111 14.10
2025-01-07 2025-01-06 4 TGTX TG THERAPEUTICS, INC.
Common Stock
S - Sale -10,021 660,611 -1.49 28.53 -285,939 18,849,874
2025-01-07 2025-01-03 4 TGTX TG THERAPEUTICS, INC.
Common Stock
S - Sale -11,337 670,632 -1.66 30.29 -343,443 20,316,126
2024-02-14 2023-12-15 5 TGTX TG THERAPEUTICS, INC.
Common Stock
G - Gift -40,000 641,969 -5.87
2024-01-05 2024-01-05 4 TGTX TG THERAPEUTICS, INC.
Common Stock
A - Award 75,000 681,969 12.36
2024-01-05 2024-01-03 4 TGTX TG THERAPEUTICS, INC.
Common Stock
S - Sale -47,867 606,969 -7.31 16.91 -809,431 10,263,846
2023-06-05 2023-06-02 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -73,647 654,836 -10.11 26.70 -1,966,375 17,484,121
2023-03-14 2023-03-12 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
A - Award 85,000 728,483 13.21
2022-07-22 2022-07-20 4 TGTX TG THERAPEUTICS, INC.
Common Stock
A - Award 75,000 643,483 13.19
2022-01-07 2022-01-05 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -9,653 568,483 -1.67 18.31 -176,746 10,408,924
2022-01-07 2022-01-04 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -75,312 578,136 -11.53 19.20 -1,445,990 11,100,211
2021-06-22 2021-06-18 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
A - Award 25,000 653,448 3.98
2021-02-12 2020-12-21 5 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
G - Gift -7,000 629,438 -1.10
2021-02-12 2020-10-09 5 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
G - Gift -125,000 636,438 -16.42
2021-01-04 2020-12-30 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
A - Award 20,000 653,338 3.16
2020-07-20 2020-07-16 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
A - Award 200,000 633,338 46.15
2020-07-20 2020-07-16 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
A - Award 50,000 433,338 13.04
2019-07-03 2019-07-01 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -17,654 383,338 -4.40 8.47 -149,529 3,246,873
2019-01-03 2019-01-02 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -37,275 400,992 -8.51 4.13 -153,946 1,656,097
2019-01-03 2018-12-31 4 TGTX TG THERAPEUTICS, INC.
Employee Stock Option (Right to Buy)
A - Award 115,000 115,000
2018-07-05 2018-07-03 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -35,000 438,267 -7.40 13.19 -461,650 5,780,742
2018-07-05 2018-07-02 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -12,191 473,267 -2.51 13.26 -161,653 6,275,520
2018-01-03 2018-01-02 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -32,006 485,458 -6.19 8.50 -272,051 4,126,393
2018-01-03 2017-12-29 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
A - Award 70,000 517,464 15.64
2017-06-19 2017-06-19 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -30,000 447,464 -6.28 11.04 -331,200 4,940,003
2017-06-19 2017-06-16 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -29,976 477,464 -5.91 11.14 -333,933 5,318,949
2017-01-04 2017-01-04 4 TGTX TG THERAPEUTICS, INC.
Common Stock
S - Sale -8,816 507,440 -1.71 4.55 -40,113 2,308,852
2017-01-04 2016-12-30 4 TGTX TG THERAPEUTICS, INC.
Common Stock
A - Award 100,000 516,256 24.02
2016-07-08 2016-07-05 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -50,426 416,256 -10.81 5.99 -302,052 2,493,373
2016-04-20 2016-04-18 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -10,000 466,682 -2.10 10.12 -101,200 4,722,822
2016-01-07 2016-01-05 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -22,790 476,682 -4.56 11.21 -255,476 5,343,605
2016-01-04 2015-12-31 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
A - Award 50,000 499,472 11.12
2015-07-02 2015-07-01 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -50,054 449,472 -10.02 16.46 -823,889 7,398,309
2015-04-03 2015-04-02 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -11,000 499,526 -2.15 15.51 -170,610 7,747,648
2015-04-03 2015-04-01 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -12,800 510,526 -2.45 15.50 -198,400 7,913,153
2015-01-07 2015-01-07 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -12,344 523,326 -2.30 16.40 -202,442 8,582,546
2015-01-07 2015-01-05 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -54,057 535,670 -9.17 16.40 -886,448 8,784,131
2015-01-02 2014-12-30 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
A - Award 10,000 589,727 1.72
2014-12-18 2014-12-16 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
S - Sale -38,041 579,727 -6.16 16.44 -625,394 9,530,712
2014-01-02 2013-12-30 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
A - Award 75,000 617,768 13.82
2014-01-02 2013-11-21 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
F - Taxes -23,106 542,768 -4.08 5.38 -124,310 2,920,092
2013-01-02 2012-12-28 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
A - Award 75,000 565,874 15.28
2013-01-02 2012-05-17 4 TGTX TG THERAPEUTICS, INC.
COMMON STOCK
F - Taxes -13,526 490,874 -2.68 6.25 -84,538 3,067,962
2012-09-17 2012-09-14 4 TGTXD TG THERAPEUTICS, INC.
COMMON STOCK
P - Purchase 3,400 504,400 0.68 2.28 7,752 1,150,032
2012-09-17 2012-09-13 4 TGTXD TG THERAPEUTICS, INC.
COMMON STOCK
P - Purchase 1,000 501,000 0.20 2.25 2,250 1,127,250
2012-05-17 2012-05-16 4 TGTXD TG THERAPEUTICS, INC.
COMMON STOCK
A - Award 350,000 500,000 233.33
2012-05-17 2012-04-30 4 TGTXD TG THERAPEUTICS, INC.
SERIES A PREFERRED STOCK
C - Conversion -16,875 0 -100.00
2012-05-17 2012-04-30 4 TGTXD TG THERAPEUTICS, INC.
COMMON STOCK
C - Conversion 150,000 150,000
2012-01-09 3 MHAN MANHATTAN PHARMACEUTICALS INC
Series A Preferred Stock
16,875
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)